U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H28N4O6
Molecular Weight 468.5023
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LAMIFIBAN

SMILES

NC(=N)C1=CC=C(C=C1)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N3CCC(CC3)OCC(O)=O

InChI

InChIKey=FPKOGTAFKSLZLD-FQEVSTJZSA-N
InChI=1S/C24H28N4O6/c25-22(26)16-3-5-17(6-4-16)23(32)27-20(13-15-1-7-18(29)8-2-15)24(33)28-11-9-19(10-12-28)34-14-21(30)31/h1-8,19-20,29H,9-14H2,(H3,25,26)(H,27,32)(H,30,31)/t20-/m0/s1

HIDE SMILES / InChI

Molecular Formula C24H28N4O6
Molecular Weight 468.5023
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

LAMIFIBAN is a potent and selective nonpeptide glycoprotein IIb/IIIa antagonist. It inhibits platelet aggregation and thrombus formation by preventing the binding of fibrinogen to platelets. It was in clinical development as an injectable antithrombotic agent for treating and preventing acute coronary syndromes but showed no significant effects on clinical outcomes.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1.4 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines.
1996 Aug 2
Lamifiban.
1999 Feb
Lamifiban.
1999 May
Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes.
2002 Jan 22
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:57:18 GMT 2023
Edited
by admin
on Fri Dec 15 15:57:18 GMT 2023
Record UNII
9XOE28082S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LAMIFIBAN
INN   MART.   MI   USAN   WHO-DD  
USAN   INN  
Official Name English
((1-(N-(P-AMIDINOBENZOYL)-L-TYROSYL)-4-PIPERIDYL)OXY)ACETIC ACID
Common Name English
RO-44-9883/000
Code English
LAMIFIBAN [USAN]
Common Name English
Lamifiban [WHO-DD]
Common Name English
LAMIFIBAN [MART.]
Common Name English
ACETIC ACID, ((1-(2-((4-(AMINOIMINOMETHYL)BENZOYL)AMINO)-3-(4-HYDROXYPHENYL)-1-OXOPROPYL)-4-PIPERIDINYL)OXY)-, (S)-
Common Name English
lamifiban [INN]
Common Name English
RO 44-9883/000
Code English
LAMIFIBAN [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1327
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
Code System Code Type Description
SMS_ID
100000082551
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
EPA CompTox
DTXSID20869939
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
FDA UNII
9XOE28082S
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
MERCK INDEX
m6669
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY Merck Index
EVMPD
SUB08391MIG
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
INN
7307
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
NCI_THESAURUS
C83862
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
CAS
144412-49-7
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
USAN
HH-38
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
ChEMBL
CHEMBL108111
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
MESH
C084062
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
PUBCHEM
3038484
Created by admin on Fri Dec 15 15:57:19 GMT 2023 , Edited by admin on Fri Dec 15 15:57:19 GMT 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY